Skip to Content


In the US, Lacosamide (lacosamide systemic) is a member of the drug class miscellaneous anticonvulsants and is used to treat Seizures.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiepileptic agent

Chemical Names

(R)-2-(acetylamino)-N-benzyl-3-metoxypropanamid (IUPAC)


(2R)-2-(acetylamino)-N-benzyl-3-metoxypropanamide (WHO)

Propanamide, 2-(acetylamino)-3-metoxy-N-(phenylmetyl)-, (2R)- (USAN)

Foreign Names

  • Lacosamidum (Latin)
  • Lacosamid (German)
  • Lacosamide (French)
  • Lacosamida (Spanish)

Generic Names

  • Lacosamide (OS: USAN, BAN)
  • ADD 243037 (IS)
  • Erlosamide (IS)
  • Harkoseride (IS)
  • SPM 927 (IS: SchwarzPharma)

Brand Names

  • Aldinam
    Drugtech, Chile
  • Andovimpamide
    Andalous, Egypt
  • Entaxar
    Pharma Investi de Chile, Chile
  • Lacasa
    Zydus, India
  • Lacotem
    Raffo, Argentina
  • Vimpat
    Abbott, Thailand; Bagó, Argentina; bioCSL, New Zealand; Biopas, Colombia; Ebewe, Georgia; Laboratorios Andromaco, Chile; Medis Adria, Croatia (Hrvatska); Schwarz, Georgia; UCB, Australia; UCB, Canada; UCB, Czech Republic; UCB, Denmark; UCB, Finland; UCB, Greece; UCB, Hong Kong; UCB, Hungary; UCB, Ireland; UCB, Iceland; UCB, Lebanon; UCB, Lithuania; UCB, Netherlands; UCB, Norway; UCB, Poland; UCB, Portugal; UCB, Romania; UCB, Slovakia; UCB, United States; UCB de Mexico, Mexico; UCB Nordic, Sweden; UCB Pharma, Austria; UCB Pharma, Belgium; UCB Pharma, Germany; UCB Pharma, Spain; UCB Pharma, France; UCB Pharma, United Kingdom; UCB Pharma, Italy; UCB Pharma, Slovenia; UCB-Pharma, Switzerland


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.